BR0300167A - Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasma - Google Patents
Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasmaInfo
- Publication number
- BR0300167A BR0300167A BR0300167A BR0300167A BR0300167A BR 0300167 A BR0300167 A BR 0300167A BR 0300167 A BR0300167 A BR 0300167A BR 0300167 A BR0300167 A BR 0300167A BR 0300167 A BR0300167 A BR 0300167A
- Authority
- BR
- Brazil
- Prior art keywords
- fraction
- lipid
- blood plasma
- pharmaceutical preparation
- free fraction
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"PREPARAçãO FARMACêUTICA PARA O TRATAMENTO E DIAGNóSTICO DE TUMORES E PROCESSO PARA PREPARAçãO DA FRAçãO LIVRE DE LIPìDEO DE PLASMA DE SANGUE". Preparação farmacêutica para o tratamento e cuidados de acompanhamento de tumores que compreende o plasma de sangue ou pre-determinados componentes de plasma de sangue de animais artiodactila com números pares de dedos, preferivelmente gado não sendo letalmente ameaçado por leucose. A fração predeterminada é o material bovin 40 e/ou bovin 300 constituindo a diferença detectável por eletroforese entre a fração livre de lipídeos tomada de um gado tendo leucose e a fração livre de lipídeos tomada de um gado saudável. No processo de separação da fração requerida o sangue inicial é opcionalmente tratado por um anticoagulante e os corpúsculos são separados do mesmo, a fração plasma é tratada por um primeiro solvente orgânico, então um material tensoativo composto por grãos finos é adicionado à mesma, o líquido é misturado e a fração livre de lipídeos ligada aos grãos é separada dos componentes líquidos por centrifugação, e a fração separada é novamente colocada em uma solução."PHARMACEUTICAL PREPARATION FOR TUMOR TREATMENT AND DIAGNOSIS AND PROCESS FOR PREPARING BLOOD PLASMA LIPID FREE FRACTION". Pharmaceutical preparation for the treatment and follow-up care of tumors comprising the blood plasma or predetermined artiodactyl animal blood plasma components with even finger numbers, preferably cattle being not lethally threatened by leukosis. The predetermined fraction is bovine 40 and / or bovin 300 material constituting the detectable difference by electrophoresis between the lipid free fraction taken from a leukose cattle and the lipid free fraction taken from a healthy cattle. In the separation process of the required fraction the starting blood is optionally treated by an anticoagulant and the corpuscles are separated from it, the plasma fraction is treated by a first organic solvent, then a fine grain surfactant is added to it, the liquid It is mixed and the grain-bound lipid-free fraction is separated from the liquid components by centrifugation, and the separated fraction is again placed in a solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0300167A BR0300167A (en) | 2003-01-30 | 2003-01-30 | Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0300167A BR0300167A (en) | 2003-01-30 | 2003-01-30 | Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0300167A true BR0300167A (en) | 2004-10-26 |
Family
ID=33163565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0300167A BR0300167A (en) | 2003-01-30 | 2003-01-30 | Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasma |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR0300167A (en) |
-
2003
- 2003-01-30 BR BR0300167A patent/BR0300167A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tevlin et al. | Pharmacological rescue of diabetic skeletal stem cell niches | |
| Chen et al. | Electroacupuncture at the Quchi and Zusanli acupoints exerts neuroprotective role in cerebral ischemia-reperfusion injured rats via activation of the PI3K/Akt pathway | |
| Garry et al. | Cardiotoxin induced injury and skeletal muscle regeneration | |
| BRPI0408928A (en) | methods to determine a disease situation in a patient, an apoptotic situation of cells in a sample, and a cancer situation in a patient | |
| BR9710452A (en) | Anïïlogos of exendin processes for its preparation and medicines containing the same | |
| Hjorth et al. | Allergic contact dermatitis in veterinary surgeons. | |
| BR0110091A (en) | Compositions and processes for breast cancer therapy and diagnosis | |
| Varni et al. | Behavioral and neurochemical aspects of pediatric pain | |
| Seriff et al. | Chylothorax: diagnosis by lipoprotein electrophoresis of serum and pleural fluid. | |
| ES2077670T3 (en) | METHODS AND COMPOSITIONS USED FOR EARLY DETECTION AND TREATMENT OF INSULIN DEPENDENT DIABETES MELLITUS. | |
| McDermott | Venom back in vogue as a wellspring for drug candidates | |
| PT820303E (en) | ANALYSIS OF P277 PEPTIDE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES | |
| Yokoyama et al. | Impaired skin barrier function in mice with colon carcinoma induced by azoxymethane and dextran sodium sulfate | |
| Wan et al. | TT‑1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl‑2 and Bax | |
| STOKES | CUTANEOUS DISEASES | |
| DE60141323D1 (en) | LOW DENSITY LIPOPROTEIN-BINDING PROTEINS AND THEIR USE IN DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS | |
| BR0300167A (en) | Pharmaceutical preparation for the treatment and diagnosis of tumors and process for preparing the lipid-free fraction of blood plasma | |
| FR2837704B1 (en) | USE OF SAPOGENINE, OR NATURAL EXTRACT CONTAINING THEM, FOR THE TREATMENT OF OLIGOSEBORRHEIC DRY SKINS | |
| Lerman | The physiology of the thyroid gland | |
| YU9903A (en) | Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma | |
| Badri et al. | Photo-onycholysis: two cases induced by doxycycline | |
| Lee et al. | Poor response of phototherapy in segmental vitiligo with leukotrichia: role of digital microscopy. | |
| Doherty et al. | Erythema multiforme–like presentation of chronic graft versus host disease | |
| Sheppard | Cancer of stomach and ABO blood groups | |
| CN101778639A (en) | Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03H | Publication of an application: rectification | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/14, A61P 37/04, A61P 35/00 Ipc: A61K 35/16 (2006.01), A61P 35/00 (2006.01), A61P 3 |